Raymond James analyst Andrew Cooper added Haemonetics (HAE) to the firm’s Analyst Current Favorites list. The list contains the current favorite stock ideas from the firm’s equity analysts. An analyst may only have one “buy” idea on the list at any given time.
Pick the best stocks and maximize your portfolio:
- Discover top-rated stocks from highly ranked analysts with Analyst Top Stocks!
- Easily identify outperforming stocks and invest smarter with Top Smart Score Stocks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on HAE:
- Haemonetics upgraded to Strong Buy from Outperform at Raymond James
- Haemonetics’ Q2 2025 Earnings Show Strong Growth
- Haemonetics backs FY25 adjusted EPS view $4.45-$4.75, consensus $4.59
- Haemonetics reports Q2 adjusted EPS $1.12, consensus $1.07
- HAE Earnings Report this Week: Is It a Buy, Ahead of Earnings?